This site looks better in landscape mode! Turn your device on its side!
Skip to content
AKLRD develops novel solutions for inflammatory diseases with a high unmet need
The burden to society of osteoarthritis in developed counties is more than 2% annual GDP
New studies suggests APPA protects against joint damage
APPA Phase II human study completes ahead of schedule
Personalised Medicine & Disease Modification in OA